Mechanism of action of glucophage
Pro Research Analysisby 
Searched over 200M research papers
Mechanism of Action of Glucophage (Metformin)
Introduction to Glucophage and Its Mechanism
Glucophage, commonly known as metformin, is a widely used medication for the treatment of type 2 diabetes. It primarily functions by improving insulin sensitivity and reducing hepatic glucose production. This article delves into the detailed mechanisms through which Glucophage exerts its effects, focusing on its interaction with cellular pathways and its impact on inflammation and immune responses.
Inhibition of Janus Kinase-STAT Signaling Pathway
One of the key mechanisms by which Glucophage operates is through the inhibition of the Janus kinase-STAT signaling pathway. This pathway is crucial for the activation of various cytokines, including IL-2, IL-12, and IFN-γ, which are involved in inflammatory responses. Studies have shown that glucocorticoids (GCs), which share some mechanistic pathways with metformin, can inhibit the activation of STAT1 by IFN-γ. This inhibition is achieved through the down-regulation of STAT1 expression, particularly in macrophages, thereby reducing the inflammatory response1 2.
Recruitment of the COMPASS Complex
Glucophage also influences gene expression by interacting with the glucocorticoid receptor (GR). The GR recruits the COMPASS complex, a histone methyltransferase, to specific regulatory elements in the genome. This recruitment leads to changes in histone methylation patterns, which in turn regulate the transcription of genes involved in inflammation. The SETD1A/COMPASS complex is essential for the GR-controlled transcription of certain macrophage target genes, highlighting a sophisticated level of gene regulation mediated by Glucophage3.
Synthesis of Glucocorticoid-Induced Leucine Zipper (GILZ)
Another significant mechanism involves the synthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages. GILZ is known to inhibit the nuclear factor kappaB (NF-κB) pathway, which is a major driver of inflammation. By stimulating the production of GILZ, Glucophage can effectively reduce the expression of pro-inflammatory cytokines and chemokines, thereby exerting its anti-inflammatory and immunosuppressive effects4.
Concentration-Dependent Effects on Macrophage Function
The effects of Glucophage on macrophage function are also concentration-dependent. At low concentrations, Glucophage can enhance the production of nitric oxide (NO) and the expression of pro-inflammatory cytokines. However, at higher concentrations, it strongly represses these functions. This dual action is primarily mediated through the glucocorticoid receptor (GR), which underscores the importance of dosage in the therapeutic application of Glucophage6.
Modulation of Chromatin Accessibility
Glucophage also modulates chromatin accessibility, which affects the transcriptional landscape of macrophages. By inhibiting the interaction of NF-κB with chromatin, Glucophage can prevent the transcription of pro-inflammatory genes. This mechanism is particularly relevant in clinical settings where Glucophage is administered during ongoing inflammatory responses, as it helps in ameliorating the disruption of metabolic genes7.
Conclusion
In summary, Glucophage exerts its therapeutic effects through multiple mechanisms, including the inhibition of the Janus kinase-STAT signaling pathway, recruitment of the COMPASS complex, synthesis of GILZ, concentration-dependent modulation of macrophage function, and alteration of chromatin accessibility. These multifaceted actions contribute to its efficacy in managing type 2 diabetes and its associated inflammatory conditions. Understanding these mechanisms provides valuable insights into the broader applications of Glucophage in clinical practice.
Sources and full results
Most relevant research papers on this topic
Inhibition of IFN-γ Signaling by Glucocorticoids1
Glucocorticoids contribute to their immunosuppressive action by inhibiting IFN- signaling through regulating STAT1 expression in macrophages.
In Vitro Study
Highly CitedInhibition of IFN-gamma signaling by glucocorticoids.
Glucocorticoids contribute to their immunosuppressive action by inhibiting IFN-gamma signaling through regulating STAT1 expression in macrophages.
In Vitro StudyThe glucocorticoid receptor recruits the COMPASS complex to regulate inflammatory transcription at macrophage enhancers
The glucocorticoid receptor recruits the SETD1A/COMPASS complex to regulate inflammatory transcription in activated macrophages, mediating its anti-inflammatory effects.
In Vitro Study
Rigorous JournalSynthesis of glucocorticoid-induced leucine zipper (GILZ) by macrophages: an anti-inflammatory and immunosuppressive mechanism shared by glucocorticoids and IL-10.
GILZ plays a key role in the anti-inflammatory and immunosuppressive effects of glucocorticoids and IL-10, with its production potentially contributing to the immune system's failure to reject tumors.
In Vitro StudyHighly CitedRegulation and role of glycophagy in skeletal muscle energy metabolism
Glycophagy is dynamically regulated in skeletal muscle, playing a role beyond just degrading glycogen to regulating energy metabolism and insulin action.
In Vitro StudyGlucocorticoids exert opposing effects on macrophage function dependent on their concentration
Glucocorticoids have distinct effects on macrophage function depending on their concentration, primarily acting through the glucocorticoid receptor (GR) despite concurrent expression of the mineralocorticoid receptor (MR).
In Vitro StudyHighly CitedAnti‐Inflammatory Chromatinscape Suggests Alternative Mechanisms of Glucocorticoid Receptor Action
Late glucocorticoid receptor activation in macrophages modulates the "inflamed epigenome" by blocking NF-B interaction and inducing inhibitors of NF-B and AP-1.
In Vitro StudyRigorous JournalHighly CitedToll‐like receptor‐4‐mediated macrophage activation is differentially regulated by progesterone via the glucocorticoid and progesterone receptors
Progesterone reduces nitric oxide production in macrophages through the glucocorticoid receptor, but also downregulates IL-12 production, suggesting its role in increased susceptibility to Toxoplasma gondii during pregnancy.
In Vitro StudyHighly CitedMore Than Suppression: Glucocorticoid Action on Monocytes and Macrophages
Glucocorticoids effectively inhibit inflammation by repressing pro-inflammatory macrophage activation and inducing anti-inflammatory monocyte and macrophage populations, potentially leading to novel therapeutic strategies for reducing inflammation with fewer side effects.
Highly CitedMacrophage migration inhibitory factor.
MIF plays a unique role in the immune system, controlling inflammation and playing a proinflammatory role in diseases like sepsis, rheumatoid arthritis, and glomerulonephritis.
Highly Cited